Results 41 to 50 of about 279,712 (174)

Validation of Neuromyotype: a smart keyboard for the evaluation of spinal muscular atrophy patients

open access: yesNeurología (English Edition)
Introduction: Spinal muscular atrophy 5q (SMA) is a genetic neurodegenerative disease that affects alpha motor neurons producing progressive weakness. New outcome measures are currently required to accurately characterise the disease progression and the ...
P. Lizandra Cortés   +7 more
doaj   +1 more source

Clinical Outcomes and Rehabilitation Requirements in Guillain–Barré Syndrome: An 18‐Year Experience From a Neurological Center in Argentina

open access: yesActa Neurologica Scandinavica, Volume 2026, Issue 1, 2026.
Background and Objectives Guillain–Barré syndrome is the most common cause of acute acquired neuromuscular paralysis worldwide and is frequently associated with significant disability requiring rehabilitation. However, data on rehabilitation requirements and their clinical predictors remain limited, particularly in low‐ and middle‐income countries.
José M. Pastor Rueda   +6 more
wiley   +1 more source

Differential gene expression of ABCG2, SLC22A12, IL-1β, and ALPK1 in peripheral blood leukocytes of primary gout patients with hyperuricemia and their comorbidities: a case–control study

open access: yesEuropean Journal of Medical Research, 2022
Background The ABCG2, SLC22A12, and ALPK1 genes have been strongly associated with dysfunction of urate metabolism in patients with gout, but it is unknown how these transporters are expressed in patients with acute or chronic gout.
Paniagua-Díaz Natsuko   +6 more
doaj   +1 more source

El pico flujo espiratorio y la cuenta máxima son marcadores del compromiso respiratorio en la miastenia gravis

open access: yesNeurología, 2023
Resumen: Introducción: La miastenia gravis (MG) es una enfermedad autoinmune mediada por anticuerpos. El cuadro clínico se caracteriza por debilidad muscular fluctuante y fatigable, con frecuente afectación de músculos fonodeglutorios y respiratorios ...
F. Aguirre   +6 more
doaj   +1 more source

Mutational spectrum and genotype–phenotype correlation in Mexican patients with infantile‐onset and late‐onset Pompe disease

open access: yesMolecular Genetics &Genomic Medicine, Volume 12, Issue 7, July 2024.
Mutational spectrum and genotype–phenotype correlation in a large case series of Pompe disease in Mexico with identification of two novel gene variants not reported previously. Abstract Background Pompe Disease (PD) is a metabolic myopathy caused by variants in the GAA gene, resulting in deficient enzymatic activity.
Valentina Martinez‐Montoya   +25 more
wiley   +1 more source

Peak expiratory flow and the single-breath count test as markers of respiratory function in patients with myasthenia gravis

open access: yesNeurología (English Edition), 2023
Introduction: Myasthenia gravis (MG) is an antibody-mediated autoimmune disease characterised by fluctuating, fatigable muscle weakness, frequently involving bulbar and respiratory muscles.
F. Aguirre   +6 more
doaj   +1 more source

Dolor en niños y adolescentes con enfermedades neuromusculares [PDF]

open access: yesRevista de la Sociedad Española del Dolor, 2013
El objetivo de este trabajo es revisar la información disponible sobre la experiencia de dolor en niños y adolescentes con una enfermedad neuromuscular (ENM). Para ello, se examinaron las bases de datos SCOPUS y MEDLINE y se localizaron los artículos publicados sobre el tema hasta marzo de 2012.
López, M., Miró, J.
openaire   +3 more sources

Tratamiento kinésico aplicado en enfermedades neuromusculares

open access: yes, 2018
Las enfermedades neuromusculares constituyen un grupo de enfermedades denominadas “raras”. Independientemente del componente neuro-muscular que este afectado, estas patologías comparten signos y síntomas comunes, siendo el síntoma más común la ...
Fossati, Vanina Micaela
core   +1 more source

Enfermedades de la placa neuromuscular

open access: yes, 2013
En este capítulo se describen las enfermedades de la placa neuromuscular, su epidemiología, hallazgos clínicos, métodos diagnósticos y tratamiento de cada una de ...
Pedroza Rojas, Alvaro   +1 more
openaire   +2 more sources

Análisis del trayecto y retraso diagnóstico de los pacientes con esclerosis lateral amiotrófica en la Comunidad Valenciana

open access: yesNeurología, 2021
Resumen: Introducción: La esclerosis lateral amiotrófica (ELA) es una enfermedad insidiosa y clínicamente heterogénea, lo que resulta en un retraso diagnóstico de unos 12 meses. En España el trayecto diagnóstico no ha sido analizado.
J.F. Vázquez-Costa   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy